Roche struck a cancer drug licensing deal with China's Hansoh that could exceed $15 billion
What happened
Hansoh will receive $400 million upfront and keep rights to the programs in mainland China, Hong Kong, Macau and Taiwan
Summary assembled by rule from the sources below